172 related articles for article (PubMed ID: 8747793)
1. Dominant contribution of 5-hydroxytryptamine over thromboxane A2 in contractile response of rabbit isolated aortic preparation to thrombin activated platelets.
Nakanishi H; Matsuoka I; Ono T; Nakahata N
Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):255-67. PubMed ID: 8747793
[TBL] [Abstract][Full Text] [Related]
2. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
Awano K; Yokoyama M; Fukuzaki H
J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
[TBL] [Abstract][Full Text] [Related]
3. Platelets increase the tone of quiescent rat aortic rings by release of serotonin and potentiate the subsequent contractile response to norepinephrine.
Yang BC; Mehta JL
J Cardiovasc Pharmacol; 1994 Mar; 23(3):387-94. PubMed ID: 7515981
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 receptor-mediated signal transduction in rabbit aortic smooth muscle cells.
Yamamoto K; Ebina S; Nakanishi H; Nakahata N
Gen Pharmacol; 1995 Nov; 26(7):1489-98. PubMed ID: 8690235
[TBL] [Abstract][Full Text] [Related]
5. Interaction of human platelets and leukocytes in modulation of vascular tone.
Kaul S; Waack BJ; Padgett RC; Brooks RM; Heistad DD
Am J Physiol; 1994 May; 266(5 Pt 2):H1706-14. PubMed ID: 8203570
[TBL] [Abstract][Full Text] [Related]
6. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.
Pakala R; Willerson JT; Benedict CR
Circulation; 1997 Oct; 96(7):2280-6. PubMed ID: 9337201
[TBL] [Abstract][Full Text] [Related]
7. APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology.
Adams JW; Ramirez J; Shi Y; Thomsen W; Frazer J; Morgan M; Edwards JE; Chen W; Teegarden BR; Xiong Y; Al-Shamma H; Behan DP; Connolly DT
J Pharmacol Exp Ther; 2009 Oct; 331(1):96-103. PubMed ID: 19628629
[TBL] [Abstract][Full Text] [Related]
8. Actions of the novel thromboxane A2 antagonists, ONO-1270 and ONO-3708, on smooth muscle cells of the guinea-pig basilar artery.
Fujioka M; Nagao T; Kuriyama H
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):468-74. PubMed ID: 3821937
[TBL] [Abstract][Full Text] [Related]
9. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
10. Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro.
Sessa WC; Mullane KM
Br J Pharmacol; 1990 Mar; 99(3):553-9. PubMed ID: 2110018
[TBL] [Abstract][Full Text] [Related]
11. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
12. Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells.
Mitsuhashi M; Tanaka A; Fujisawa C; Kawamoto K; Itakura A; Takaku M; Hironaka T; Sawada S; Matsuda H
J Immunol; 2001 Jan; 166(1):617-23. PubMed ID: 11123345
[TBL] [Abstract][Full Text] [Related]
13. [Vasoconstrictor responses of isolated pig coronary arteries].
Ikenoue K; Kawakita S; Toda N
Nihon Yakurigaku Zasshi; 1986 Mar; 87(3):281-90. PubMed ID: 3011619
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 potentiates thrombin-induced proliferation of coronary artery smooth muscle cells.
Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K
Adv Exp Med Biol; 1997; 433():387-90. PubMed ID: 9561177
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
[TBL] [Abstract][Full Text] [Related]
16. Interactions between 5-hydroxytryptamine, noradrenaline and the thromboxane-A2 mimetic U44069 in the marmoset isolated aorta.
Dyer SM; Bexis S; Mano MT; de la Lande IS; Frewin DB; Head RJ
Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):201-6. PubMed ID: 8076422
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2 receptor-mediated tonic contraction is attributed to an activation of phosphatidylcholine-specific phospholipase C in rabbit aortic smooth muscles.
Nakahata N; Takano H; Ohizumi Y
Life Sci; 2000; 66(5):PL 71-6. PubMed ID: 10670835
[TBL] [Abstract][Full Text] [Related]
18. I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle.
Lu N; Zhan M; Gao C; Wu G; Zhang H
Thromb Res; 2012 Oct; 130(4):e209-15. PubMed ID: 22909828
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
Cohen RA; Shepherd JT; Vanhoutte PM
Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
[TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxytryptamine and thromboxane A2 in ischaemic heart disease.
De Clerck F; Janssen PA
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):201-9. PubMed ID: 2130932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
